Avid Bioservices, Inc. (CDMO)
After hours:
| Previous Close | 18.03 |
| Open | 18.05 |
| Bid | 17.96 x 1800 |
| Ask | 19.75 x 1000 |
| Day's Range | 17.00 - 18.04 |
| 52 Week Range | 11.30 - 34.51 |
| Volume | |
| Avg. Volume | 575,041 |
| Market Cap | 1.116B |
| Beta (5Y Monthly) | 2.16 |
| PE Ratio (TTM) | 10.26 |
| EPS (TTM) | 1.75 |
| Earnings Date | Dec 05, 2022 - Dec 09, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 26.67 |
- GlobeNewswire
Avid Bioservices Appoints Michael Alston, Jr. as Vice President, Operations
Accomplished Operations Professional Promoted from Role as Director of Project Engineering; Credited with Leading All of the Company’s Ongoing Facility Expansion ProjectsTUSTIN, Calif., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced
- Simply Wall St.
We Ran A Stock Scan For Earnings Growth And Avid Bioservices (NASDAQ:CDMO) Passed With Ease
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...
- GlobeNewswire
Avid Bioservices to Participate in Morgan Stanley 20th Annual Global Healthcare Conference
TUSTIN, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that the company will participate in the Morgan Stanley 20th Annual Global Healthcare Conference. Nick Green, president and chief executive officer of Avid Bioservices,
